(Q54486623)

30 May 2018

title

Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid. (English)

1 reference

30 May 2018

main subject

Staphylococcus aureus

1 reference

P Casey

1

1 reference

30 May 2018

M Glauser

series ordinal

2

1 reference

30 May 2018

publication date

1 December 1983

1 reference

30 May 2018

European journal of clinical microbiology

published in

1 reference

30 May 2018

volume

2

1 reference

30 May 2018

issue

6

1 reference

30 May 2018

page(s)

541-547

1 reference

30 May 2018

Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02016562

Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02016562

Clavulanic Acid, a Novel Inhibitor of β-Lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02016562

In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02016562

Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02016562

Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02016562

Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid

21 January 2018

1 reference

12 December 2020

Ticarcillin: a review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.

1 reference

12 December 2020

Amoxycillin and clavulanic acid in intra-abdominal and pelvic sepsis

1 reference

12 December 2020

Azlocillin and mezlocillin: new ureido penicillins

1 reference

12 December 2020

Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes

1 reference

12 December 2020

In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin

1 reference

12 December 2020

Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study

1 reference

12 December 2020

Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics

1 reference

12 December 2020

[Bactericidal activity against P. aeruginosa in serum and bronchial secretion in patients under continuous infusion of azlocillin]

1 reference

12 December 2020

Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

1 reference

12 December 2020

Effect of clavulanic acid and amoxycillin formulation against β-lactamase producing Gram-negative bacteria in urinary tract infections

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02016562

1 reference

30 May 2018

PubMed ID

6607834

1 reference

30 May 2018